Ruconest prophylaxis

Pharming Group N.V. (PHGUF) Stock Message Board – InvestorsHub, Forum: Pharming » PHARMING DECEMBER 2017 » Pagina: 140, Pipeline Overview Wendell Wierenga, Ph.D. Executive Vice, Glumetza(r) Market Potential 15 (CHART) 0.4M, Glumetza(r) Market Potential 15 (CHART) 0.4M, Pharming Group (PHGUF) Investor Presentation – Slideshow, Pharming Group (PHGUF) Investor Presentation – Slideshow, Completion of patient enrolment in clinical study of, RUCONEST(r) (Recombinant human C1 esterase inhibitor) Mark, Exhibit 99.1, Q22015 earnings deck final august 11 revised, Pharming Group: A Potential Genzyme In The Making, Pharming Group: A Potential Genzyme In The Making.